International Neuromodulation Society 11th World Congress, Technology Transforming Chronic Illness Management, Expects 1,500 Participants in June 2013 in Berlin
Newswise — SAN FRANCISCO (Jan. 9, 2013) – The International Neuromodulation Society expects at least 1,500 participants at its 11th World Congress, “Technology Transforming Chronic Illness Management,” from June 8 -13, 2013, in Berlin, Germany.
What: The six-day congress, “Technology Transforming Chronic Illness Management,” is a biennial scientific conference that draws participants from six continents and presents the most comprehensive breadth of all neuromodulation therapies (official meeting language is English)
Where: The Estrel Hotel in Berlin, Germany
When: June 8 - 13, 2013
Pre-conference: Solving Problems at the Neural Interface – Saturday, June 8Innovations in Neuromodulation – Sunday, June 9
Main scientific congress: Monday, June 10 - Thursday, June 13Multiple daily tracks present the latest data on neuromodulation therapies to treat such medical conditions as:
• Parkinson’s disease and other movement disorders, epilepsy• Ischemic heart disease, heart failure, cardiac arrhythmia, hypertension• Chronic pain, chronic headache, cancer pain• Gastrointestinal or pelvic disorders• Medically refractory depression, obsessive-compulsive disorder, addictive disorders• Stroke, spinal cord injury, and traumatic brain injury
Who: An internationally renowned faculty and more than 1,500 clinicians, engineers, researchers and company representatives
Abstract deadline: Feb. 14, 2012Preliminary scientific program: http://www.neuromodulation.com/8-june-2013
General meeting information: http://www.neuromodulation.com/ins-congress
About the International Neuromodulation Society The International Neuromodulation Society (INS) is a nonprofit group of clinicians, scientists and engineers dedicated to scientific development and knowledge of the promising medical discipline of neuromodulation, a rapidly growing family of therapies developed to help relieve pain or restore function by delivering electromagnetic stimulation or chemical agents directly to specific sites in the body. Founded in 1989 and based in San Francisco, Calif., the INS has 15 current and four forming chapters worldwide, and educates and promotes the field through meetings, its journal Neuromodulation: Technology at the Neural Interface, and chapter websites. For more information, please visit www.neuromodulation.com.